475 related articles for article (PubMed ID: 38077251)
1. Receptor tyrosine kinases: biological functions and anticancer targeted therapy.
Zhang N; Li Y
MedComm (2020); 2023 Dec; 4(6):e446. PubMed ID: 38077251
[TBL] [Abstract][Full Text] [Related]
2. Activation and function of receptor tyrosine kinases in human clear cell renal cell carcinomas.
Zhang Q; Liu JH; Liu JL; Qi CT; Yan L; Chen Y; Yu Q
BMC Cancer; 2019 Nov; 19(1):1044. PubMed ID: 31690270
[TBL] [Abstract][Full Text] [Related]
3. Roles for receptor tyrosine kinases in tumor progression and implications for cancer treatment.
Ghosh S; Marrocco I; Yarden Y
Adv Cancer Res; 2020; 147():1-57. PubMed ID: 32593398
[TBL] [Abstract][Full Text] [Related]
4. Evaluating the landscape of gene cooperativity with receptor tyrosine kinases in liver tumorigenesis using transposon-mediated mutagenesis.
Fan Y; Bazai SK; Daian F; Arechederra M; Richelme S; Temiz NA; Yim A; Habermann BH; Dono R; Largaespada DA; Maina F
J Hepatol; 2019 Mar; 70(3):470-482. PubMed ID: 30529386
[TBL] [Abstract][Full Text] [Related]
5. More than the sum of the parts: Toward full-length receptor tyrosine kinase structures.
Diwanji D; Thaker T; Jura N
IUBMB Life; 2019 Jun; 71(6):706-720. PubMed ID: 31046201
[TBL] [Abstract][Full Text] [Related]
6. Resistance to receptor tyrosine kinase inhibitors in solid tumors: can we improve the cancer fighting strategy by blocking autophagy?
Aveic S; Tonini GP
Cancer Cell Int; 2016; 16():62. PubMed ID: 27486382
[TBL] [Abstract][Full Text] [Related]
7. Discoidin domain receptor tyrosine kinases: new players in cancer progression.
Valiathan RR; Marco M; Leitinger B; Kleer CG; Fridman R
Cancer Metastasis Rev; 2012 Jun; 31(1-2):295-321. PubMed ID: 22366781
[TBL] [Abstract][Full Text] [Related]
8. Context-dependent regulation of receptor tyrosine kinases: Insights from systems biology approaches.
Lam I; Pickering CM; Mac Gabhann F
Wiley Interdiscip Rev Syst Biol Med; 2019 Mar; 11(2):e1437. PubMed ID: 30255986
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of receptor tyrosine kinase activation in cancer.
Du Z; Lovly CM
Mol Cancer; 2018 Feb; 17(1):58. PubMed ID: 29455648
[TBL] [Abstract][Full Text] [Related]
10. Mislocalisation of Activated Receptor Tyrosine Kinases - Challenges for Cancer Therapy.
Schmidt-Arras D; Böhmer FD
Trends Mol Med; 2020 Sep; 26(9):833-847. PubMed ID: 32593582
[TBL] [Abstract][Full Text] [Related]
11. Targeting Receptor Tyrosine Kinases Using Monoclonal Antibodies: The Most Specific Tools for Targeted-Based Cancer Therapy.
Shabani M; Hojjat-Farsangi M
Curr Drug Targets; 2016; 17(14):1687-1703. PubMed ID: 26424402
[TBL] [Abstract][Full Text] [Related]
12. SHP2 acts both upstream and downstream of multiple receptor tyrosine kinases to promote basal-like and triple-negative breast cancer.
Matalkah F; Martin E; Zhao H; Agazie YM
Breast Cancer Res; 2016 Jan; 18(1):2. PubMed ID: 26728598
[TBL] [Abstract][Full Text] [Related]
13. Co-expression of receptor tyrosine kinases and CD8 T-lymphocyte genes is associated with distinct prognoses, immune cell infiltration patterns and immunogenicity in cancers.
Long J; Chen P; Yang X; Bian J; Yang X; Wang A; Lin Y; Wang H; Sang X; Zhao H
Transl Res; 2023 Jun; 256():14-29. PubMed ID: 36586534
[TBL] [Abstract][Full Text] [Related]
14. Receptor tyrosine kinases as target for anti-cancer therapy.
Brunelleschi S; Penengo L; Santoro MM; Gaudino G
Curr Pharm Des; 2002; 8(22):1959-72. PubMed ID: 12171522
[TBL] [Abstract][Full Text] [Related]
15. Receptor tyrosine kinases fall into distinct classes based on their inferred signaling networks.
Wagner JP; Wolf-Yadlin A; Sevecka M; Grenier JK; Root DE; Lauffenburger DA; MacBeath G
Sci Signal; 2013 Jul; 6(284):ra58. PubMed ID: 23861540
[TBL] [Abstract][Full Text] [Related]
16. Proteome-Wide Detection and Annotation of Receptor Tyrosine Kinases (RTKs): RTK-PRED and the TyReK Database.
Filis G; Baltoumas FA; Spanogiannis G; Litou ZI; Iconomidou VA
Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830638
[TBL] [Abstract][Full Text] [Related]
17. Galectins as modulators of receptor tyrosine kinases signaling in health and disease.
Porębska N; Poźniak M; Matynia A; Żukowska D; Zakrzewska M; Otlewski J; Opaliński Ł
Cytokine Growth Factor Rev; 2021 Aug; 60():89-106. PubMed ID: 33863623
[TBL] [Abstract][Full Text] [Related]
18. All Good Things Must End: Termination of Receptor Tyrosine Kinase Signal.
Margiotta A
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34198477
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of substituted pyrrolo[2,3-d]pyrimidines as multiple receptor tyrosine kinase inhibitors and antiangiogenic agents.
Gangjee A; Namjoshi OA; Yu J; Ihnat MA; Thorpe JE; Warnke LA
Bioorg Med Chem; 2008 May; 16(10):5514-28. PubMed ID: 18467105
[TBL] [Abstract][Full Text] [Related]
20. Splice Variants of the RTK Family: Their Role in Tumour Progression and Response to Targeted Therapy.
Abou-Fayçal C; Hatat AS; Gazzeri S; Eymin B
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28208660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
